RecruitingNCT06926829

A Long-term Trial of EB-1020 in Adult Patients With ADHD

This recruiting study focuses on adhd and currently lists sites or participation links in Japan.

ADHDOtherFrom 18 Years to 55 Years

In plain English

Key information made simple

This study exists to understand how the medication EB-1020 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication EB-1020 in practice and what may need to be adjusted. For people living with ADHD, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Maynds Tower Mental Clinic in Tokyo. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis and having a stable enough treatment background for the study, while common reasons not to take part include pregnancy or breastfeeding and safety concerns that need urgent care first. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06926829. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Japan.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com